About: Élisabeth Quoix

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Élisabeth Quoix Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Quoix, Élisabeth (1951-....) Quoix, Élisabeth (1951-....) Quoix, Élisabeth (1951-....)
Life Event	http://www.idref.fr/050746839/birth
bnf-onto:FRBNF	13543283(xsd:integer)
preferred label	Quoix, Élisabeth (1951-....)
name	Élisabeth Quoix
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000006546160
Given name	Élisabeth
familyName	Quoix
note	En poste au Centre hospitalier régional universitaire, Strasbourg, service de pneumonologie (en 1999)
Scopus ID	7006740165
is sameAs of	Quoix, Élisabeth (1951-....) Quoix, Élisabeth (1951-....)
is Thesis advisor of	http://www.sudoc.fr/061283207/id http://www.sudoc.fr/078853249/id http://www.sudoc.fr/102398925/id http://www.sudoc.fr/22121531X/id http://www.sudoc.fr/08359583X/id http://www.sudoc.fr/091977495/id http://www.sudoc.fr/147466563/id http://www.sudoc.fr/060063491/id http://www.sudoc.fr/041793250/id http://www.sudoc.fr/042100607/id http://www.sudoc.fr/041242254/id http://www.sudoc.fr/04226071X/id http://www.sudoc.fr/041135946/id http://www.sudoc.fr/082350213/id http://www.sudoc.fr/042101042/id http://www.sudoc.fr/079914675/id http://www.sudoc.fr/053689445/id
is Author of	http://www.sudoc.fr/177435283/id http://www.sudoc.fr/049962493/id http://www.sudoc.fr/10148562X/id Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial [Lung cancer in the elderly subject] Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3 Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial No impact of passive smoke on the somatic profile of lung cancers in never-smokers Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504. Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. Chemotherapy in elderly patients with advanced non-small cell lung cancer. High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial Professional exposure to goats increases the risk of pneumonic-type lung adenocarcinoma: results of the IFCT-0504-Epidemio study. IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. https://orbi.uliege.be/handle/2268/11129#id Perception of lung cancer among a general population and comparison with other cancers. Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer Bronchoplastic lobectomy: do early results depend on the underlying pathology? Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar Carcinoma): Exploratory Analysis of the IFCT-0401 Trial. Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early-Stage Non-Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized Trials. First-line afatinib plus cetuximab for EGFR-mutant non–small cell lung cancer: Results from the randomized phase II IFCT-1503 ACE-lung study https://serval.unil.ch/notice/serval:BIB_D93B50365865#id Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. http://www.sudoc.fr/184382696/id Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study. [Management and outcome of French elderly patients with lung cancer: an IFCT survey]. Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non-Small-Cell Lung Cancer Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01. Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network [IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer] Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non–small cell lung cancer: IFCT-1201 MODEL trial Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study Perception of Lung Cancer among the General Population and Comparison with Other Cancers Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung Trial An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Etoposide Plus Cisplatin With or Without the Combination of 4′-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study Second-line therapy in elderly patients with advanced nonsmall cell lung cancer Perception of Lung Cancer among the General Population and Comparison with Other Cancers Professional exposure to goats increases the risk of pneumonic-type lung adenocarcinoma. Results of the IFCT-0504-epidemio study Should we screen patients for carotid artery disease before lung cancer resection? https://serval.unil.ch/notice/serval:BIB_E0AEE46B6996#id
is primary topic of	http://www.idref.fr/050746839
is Interviewee of	http://www.sudoc.fr/184382696/id
is Editor of	http://www.sudoc.fr/170420728/id http://www.sudoc.fr/170093891/id http://www.sudoc.fr/170406350/id http://www.sudoc.fr/170420620/id
is Opponent of	http://www.sudoc.fr/204107911/id http://www.sudoc.fr/204209749/id Les critères de jugement centrés sur le patient dans les essais cliniques en oncologie thoracique

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software